BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 29567280)

  • 1. [Hepatocellular carcinoma: Increase in incidence or future plague?].
    Raoul JL; Raimbourg J; Hiret S; Adhoute X; Senellart H
    Bull Cancer; 2018 May; 105(5):502-507. PubMed ID: 29567280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma.
    Massoud O; Charlton M
    Clin Liver Dis; 2018 Feb; 22(1):201-211. PubMed ID: 29128057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: An increasing concern.
    Dhamija E; Paul SB; Kedia S
    Indian J Med Res; 2019 Jan; 149(1):9-17. PubMed ID: 31115369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
    Streba LA; Vere CC; Rogoveanu I; Streba CT
    World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevalence and harm of nonalcoholic fatty liver disease].
    Shao YL; Fan JG
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jan; 27(1):10-13. PubMed ID: 30685917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent of Cirrhosis, Hepatocellular Carcinoma Risk Is Increased with Diabetes and Metabolic Syndrome.
    Kasmari AJ; Welch A; Liu G; Leslie D; McGarrity T; Riley T
    Am J Med; 2017 Jun; 130(6):746.e1-746.e7. PubMed ID: 28109969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Epidemiology of Hepatocellular Carcinoma in the USA.
    Kim HS; El-Serag HB
    Curr Gastroenterol Rep; 2019 Apr; 21(4):17. PubMed ID: 30976932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review: chronic viral hepatitis and metabolic derangement.
    Wang CC; Cheng PN; Kao JH
    Aliment Pharmacol Ther; 2020 Jan; 51(2):216-230. PubMed ID: 31746482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic Fatty liver disease, diabetes, obesity, and hepatocellular carcinoma.
    Noureddin M; Rinella ME
    Clin Liver Dis; 2015 May; 19(2):361-79. PubMed ID: 25921668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular carcinoma and non-alcoholic fatty liver disease.
    Golabi P; Rhea L; Henry L; Younossi ZM
    Hepatol Int; 2019 Nov; 13(6):688-694. PubMed ID: 31701393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epidemiology of non-alcoholic fatty liver disease.
    Bellentani S
    Liver Int; 2017 Jan; 37 Suppl 1():81-84. PubMed ID: 28052624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral hepatitis and hepatocellular carcinoma.
    Marrero CR; Marrero JA
    Arch Med Res; 2007 Aug; 38(6):612-20. PubMed ID: 17613352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The story of HCC in NAFLD: from epidemiology, across pathogenesis, to prevention and treatment.
    Margini C; Dufour JF
    Liver Int; 2016 Mar; 36(3):317-24. PubMed ID: 26601627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma and metabolic syndrome: The times are changing and so should we.
    Tsoulfas G
    World J Gastroenterol; 2019 Aug; 25(29):3842-3848. PubMed ID: 31413522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic fatty liver disease increases the risk of hepatocellular carcinoma in patients with alcohol-associated cirrhosis awaiting liver transplants.
    Pais R; Lebray P; Rousseau G; Charlotte F; Esselma G; Savier E; Thabut D; Rudler M; Eyraud D; Vezinet C; Siksik JM; Vaillant JC; Hannoun L; Poynard T; Ratziu V
    Clin Gastroenterol Hepatol; 2015 May; 13(5):992-9.e2. PubMed ID: 25459558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma: A Growing Epidemic?
    Yopp AC; Choti MA
    Dig Dis; 2015 Sep; 33(5):642-7. PubMed ID: 26398208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Non-alcoholic fatty liver disease and hepatocellular carcinoma - 2016].
    Pár A; Pár G
    Orv Hetil; 2016 Jun; 157(25):987-94. PubMed ID: 27287838
    [TBL] [Abstract][Full Text] [Related]  

  • 18.  Economic growth leads to increase of obesity and associated hepatocellular carcinoma in developing countries.
    Seyda Seydel G; Kucukoglu O; Altinbasv A; Demir OO; Yilmaz S; Akkiz H; Otan E; Sowa JP; Canbay A
    Ann Hepatol; 2016; 15(5):662-72. PubMed ID: 27493104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for non-alcoholic fatty liver disease are common in patients with non-B non-C hepatocellular carcinoma in India.
    David D; Raghavendran A; Goel A; Bharath Kumar C; Kodiatte TA; Burad D; Abraham P; Ramakrishna B; Joseph P; Ramachandran J; Eapen CE
    Indian J Gastroenterol; 2017 Sep; 36(5):373-379. PubMed ID: 28975595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between hepatocellular carcinoma, metabolic syndrome and non-alcoholic fatty liver disease: which clinical arguments?
    Rosmorduc O
    Ann Endocrinol (Paris); 2013 May; 74(2):115-20. PubMed ID: 23597944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.